Logo image of BRLI

BRILLIANT ACQUISITION CORP (BRLI) Stock Fundamental Analysis

NASDAQ:BRLI - Nasdaq - VGG1643W1115 - Common Stock - Currency: USD

4.7  -3.69 (-43.95%)

After market: 6.2 +1.5 (+31.91%)

Fundamental Rating

0

We assign a fundamental rating of 0 out of 10 to BRLI. BRLI was compared to 0 industry peers in the Unkown industry. Both the profitability and financial health of BRLI have multiple concerns. BRLI is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year BRLI has reported negative net income.
BRLI had a negative operating cash flow in the past year.
BRLI Yearly Net Income VS EBIT VS OCF VS FCFBRLI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 -200K -400K -600K -800K -1M

1.2 Ratios

Industry RankSector Rank
ROA -17.61%
ROE -1012.5%
ROIC N/A
ROA(3y)-5.94%
ROA(5y)N/A
ROE(3y)-15.78%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BRLI Yearly ROA, ROE, ROICBRLI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 -10 -20 -30 -40

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for BRLI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BRLI Yearly Profit, Operating, Gross MarginsBRLI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022

More info and screens

1

2. Health

2.1 Basic Checks

Compared to 1 year ago, BRLI has less shares outstanding
The debt/assets ratio for BRLI is higher compared to a year ago.
BRLI Yearly Shares OutstandingBRLI Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2M 4M 6M
BRLI Yearly Total Debt VS Total AssetsBRLI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 10M 20M 30M 40M

2.2 Solvency

BRLI has an Altman-Z score of -2.04. This is a bad value and indicates that BRLI is not financially healthy and even has some risk of bankruptcy.
A Debt/Equity ratio of 50.38 is on the high side and indicates that BRLI has dependencies on debt financing.
Industry RankSector Rank
Debt/Equity 50.38
Debt/FCF N/A
Altman-Z -2.04
ROIC/WACCN/A
WACCN/A
BRLI Yearly LT Debt VS Equity VS FCFBRLI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 0 10M 20M 30M 40M

2.3 Liquidity

A Current Ratio of 1.02 indicates that BRLI should not have too much problems paying its short term obligations.
BRLI has a Quick Ratio of 1.02. This is a normal value and indicates that BRLI is financially healthy and should not expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 1.02
Quick Ratio 1.02
BRLI Yearly Current Assets VS Current LiabilitesBRLI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 10M 20M 30M 40M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for BRLI have decreased strongly by -55.56% in the last year.
EPS 1Y (TTM)-55.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-500%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BRLI Yearly Revenue VS EstimatesBRLI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022
BRLI Yearly EPS VS EstimatesBRLI Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

BRLI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BRLI Price Earnings VS Forward Price EarningsBRLI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BRLI Per share dataBRLI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.1 -0.2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

BRLI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BRILLIANT ACQUISITION CORP

NASDAQ:BRLI (12/22/2023, 8:18:25 PM)

After market: 6.2 +1.5 (+31.91%)

4.7

-3.69 (-43.95%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)11-14 2023-11-14
Earnings (Next)03-08 2024-03-08
Inst Owners9.91%
Inst Owner Change-16.13%
Ins Owners0.55%
Ins Owner Change0%
Market Cap8.51M
Analysts60
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 94.52
P/tB 94.52
EV/EBITDA N/A
EPS(TTM)-0.28
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.22
FCFYN/A
OCF(TTM)-0.22
OCFYN/A
SpS0
BVpS0.05
TBVpS0.05
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -17.61%
ROE -1012.5%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-5.94%
ROA(5y)N/A
ROE(3y)-15.78%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 50.38
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.02
Quick Ratio 1.02
Altman-Z -2.04
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-55.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-500%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y20.51%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-73.91%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-73.91%
OCF growth 3YN/A
OCF growth 5YN/A